target directory

oral cyclosporine a immune tolerance agent and oral lansoprazole proton pump inhibitor to enhance beta cell regeneration and reduce insulin requirements in type 1 diabetes mellitus clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.